These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21756406)

  • 1. Folic acid in obstetric practice: a review.
    Talaulikar VS; Arulkumaran S
    Obstet Gynecol Surv; 2011 Apr; 66(4):240-7. PubMed ID: 21756406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of folate for the prevention of neural tube defects: who benefits?
    Bower C; Miller M; Payne J; Serna P
    Paediatr Perinat Epidemiol; 2005 Nov; 19(6):435-44. PubMed ID: 16269071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
    Meijer WM; de Walle HE
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural tube defects: prevalence, etiology and prevention.
    Kondo A; Kamihira O; Ozawa H
    Int J Urol; 2009 Jan; 16(1):49-57. PubMed ID: 19120526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate and neural tube defects. Recommendations from a Danish working group.
    Rasmussen LB; Andersen NL; Andersson G; Lange AP; Rasmussen K; Skak-Iversen L; Skovby F; Ovesen L
    Dan Med Bull; 1998 Apr; 45(2):213-7. PubMed ID: 9587705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Folic acid and prevention of neural tube closure defects: the question is not solved yet].
    Vidailhet M; Bocquet A; Bresson JL; Briend A; Chouraqui JP; Dupont C; Darmaun D; Frelut ML; Ghisolfi J; Girardet JP; Goulet O; Putet G; Rieu D; Rigo J; Turck D;
    Arch Pediatr; 2008 Jul; 15(7):1223-31. PubMed ID: 18562183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should folic acid fortification be mandatory in Israel?
    Hacohen Y; Lerman-Sagie T
    Isr Med Assoc J; 2006 Sep; 8(9):649-50. PubMed ID: 17058420
    [No Abstract]   [Full Text] [Related]  

  • 8. Folate knowledge and consumer behaviour among pregnant New Zealand women prior to the potential introduction of mandatory fortification.
    Mallard SR; Houghton LA
    Asia Pac J Clin Nutr; 2012; 21(3):440-9. PubMed ID: 22705436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and use of folic acid, and blood folate concentrations among pregnant women in northern China--an area with a high prevalence of neural tube defects.
    Ren A; Zhang L; Li Z; Hao L; Tian Y; Li Z
    Reprod Toxicol; 2006 Oct; 22(3):431-6. PubMed ID: 16549319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area.
    Coll O; Pisa S; Palacio M; Quintó L; Cararach V
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):173-7. PubMed ID: 15262351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uncertain effects of folic acid on disorders other than neural-tube defects].
    Verhoef P; Katan MB
    Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1439-42. PubMed ID: 16875263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of folic acid.
    Berg MJ
    J Gend Specif Med; 1999; 2(3):24-8. PubMed ID: 11252849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service.
    Goldberg BB; Alvarado S; Chavez C; Chen BH; Dick LM; Felix RJ; Kao KK; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):193-9. PubMed ID: 16511885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of the benefits of folic acid and prevalence of the use of folic acid supplements to prevent neural tube defects among Thai women.
    Nawapun K; Phupong V
    Arch Gynecol Obstet; 2007 Jul; 276(1):53-7. PubMed ID: 17186253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
    Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
    Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid--the scientific debate as a base for public health policy.
    Cornel MC; de Smit DJ; de Jong-van den Berg LT
    Reprod Toxicol; 2005; 20(3):411-5. PubMed ID: 15978774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case for folic acid and vitamin B12 fortification in Europe.
    Czernichow S; Noisette N; Blacher J; Galan P; Mennen L; Hercberg S; Ducimetière P
    Semin Vasc Med; 2005 May; 5(2):156-62. PubMed ID: 16047267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delaying mandatory folic acid fortification policy perpetuates health inequalities: results from a retrospective study of postpartum New Zealand women.
    Mallard SR; Gray AR; Houghton LA
    Hum Reprod; 2012 Jan; 27(1):273-82. PubMed ID: 22095790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid and other potential measures in the prevention of neural tube defects.
    Heseker H
    Ann Nutr Metab; 2011; 59(1):41-5. PubMed ID: 22123637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate intakes and awareness of folate to prevent neural tube defects: a survey of women living in Vancouver, Canada.
    French MR; Barr SI; Levy-Milne R
    J Am Diet Assoc; 2003 Feb; 103(2):181-5. PubMed ID: 12589323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.